Spatial transcriptomics analysis of uterine gene expression in enhancer of zeste homolog 2 conditional knockout mice

被引:11
|
作者
Mesa, Ana M. [1 ,2 ]
Mao, Jiude [3 ,4 ]
Medrano, Theresa, I [1 ]
Bivens, Nathan J. [5 ]
Jurkevich, Alexander [6 ]
Tuteja, Geetu [7 ]
Cooke, Paul S. [1 ]
Rosenfeld, Cheryl S. [4 ,8 ,9 ]
机构
[1] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA
[2] Univ Antioquia UdeA, Fac Ciencias Agr, Grp Invest Agrociencias Biodiversidad & Terr Gamm, Medellin, Colombia
[3] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA
[4] Univ Missouri, Biomed Sci, Columbia, MO USA
[5] Univ Missouri, Genom Technol Core, Columbia, MO USA
[6] Univ Missouri, Adv Light Microscopy Core Facil, Columbia, MO USA
[7] Iowa State Univ, Genet Dev & Cell Biol, Ames, IA USA
[8] Univ Missouri, Data Sci & Informat Inst, Columbia, MO USA
[9] Univ Missouri, Thompson Ctr Autism & Neurobehav Disorders, Columbia, MO USA
基金
美国国家卫生研究院;
关键词
Female Reproduction; endometrium; RNA-seq; estrogen; endometrial cancer; epigenetics; uterus; Histone Proteins; CELL-PROLIFERATION; MIGRATION; INVASION; PROTEIN; EZH2; ENDOMETRIUM; H3K27ME3; PATHWAY; CXCL14; MODELS;
D O I
10.1093/biolre/ioab147
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Histone proteins undergo various modifications that alter chromatin structure, including addition of methyl groups. Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that methylates lysine residue 27, and thereby suppresses gene expression. EZH2 plays integral roles in the uterus and other reproductive organs. We have previously shown that conditional deletion of uterine EZH2 results in increased proliferation of luminal and glandular epithelial cells, and RNA-seq analyses reveal several uterine transcriptomic changes in Ezh2 conditional (c) knockout (KO) mice that can affect estrogen signaling pathways. To pinpoint the origin of such gene expression changes, we used the recently developed spatial transcriptomics (ST) method with the hypotheses that Ezh2cKO mice would predominantly demonstrate changes in epithelial cells and/or ablation of this gene would disrupt normal epithelial/stromal gene expression patterns. Uteri were collected from ovariectomized adult WT and Ezh2cKO mice and analyzed by ST. Asb4, Cxcl14, Dio2, and Igfbp5 were increased, Sult1d1, Mt3, and Lcn2 were reduced in Ezh2cKO uterine epithelium vs. WT epithelium. For Ezh2cKO uterine stroma, differentially expressed key hub genes included Cald1, Fbln1, Myh11, Acta2, and Tagln. Conditional loss of uterine Ezh2 also appears to shift the balance of gene expression profiles in epithelial vs. stromal tissue toward uterine epithelial cell and gland development and proliferation, consistent with uterine gland hyperplasia in these mice. Current findings provide further insight into how EZH2 may selectively affect uterine epithelial and stromal compartments. Additionally, these transcriptome data might provide mechanistic understanding and valuable biomarkers for human endometrial disorders with epigenetic underpinnings. Summary sentence Spatial transcriptomics studies reveal how EZH2 selectively affects uterine epithelial and stromal compartments, and findings may provide a mechanistic understanding and biomarkers for human endometrial disorders originating from epigenetic changes.
引用
收藏
页码:1126 / 1139
页数:14
相关论文
共 50 条
  • [1] Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer
    Kang, Yuanyuan
    Zhang, Ying
    Sun, Yan
    FRONTIERS IN GENETICS, 2021, 12
  • [2] Mice lacking uterine enhancer of zeste homolog 2 have transcriptomic changes associated with uterine epithelial proliferation
    Mesa, Ana M.
    Mao, Jiude
    Nanjappa, Manjunatha K.
    Medrano, Thera, I
    Tevosian, Sergei
    Yu, Fahong
    Kinkade, Jessica
    Lyu, Zhen
    Liu, Yang
    Joshi, Trupti
    Wang, Duolin
    Rosenfeld, Cheryl S.
    Cooke, Paul S.
    PHYSIOLOGICAL GENOMICS, 2020, 52 (02) : 81 - 95
  • [3] The expression and significance of the enhancer of zeste homolog 2 in lung adenocarcinoma
    Lv, Yijing
    Yuan, Cunzhong
    Xiao, Xiaoyan
    Wang, Xuping
    Ji, Xuming
    Yu, Huayun
    Wu, Zhichun
    Zhang, Jidong
    ONCOLOGY REPORTS, 2012, 28 (01) : 147 - 154
  • [4] Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer
    Warrick, Joshua I.
    Raman, Jay D.
    Kaag, Matthew
    Bruggeman, Trey
    Cates, Justin
    Clark, Peter
    DeGraff, David J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 258.e1 - 258.e6
  • [5] Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases
    Mimori, K
    Ogawa, K
    Okamoto, M
    Sudo, T
    Inoue, H
    Mori, M
    EJSO, 2005, 31 (04): : 376 - 380
  • [6] Abundant expression of enhancer of zeste homolog 2 in small cell lung cancer
    Watanabe, Yasutaka
    Koyama, Nobuyuki
    Iwai, Yuki
    Miwa, Chihiro
    Koyama, Shinichiro
    CANCER RESEARCH, 2015, 75
  • [7] The polycomb protein, enhancer of zeste (Homolog) 2 (EZH-2), is consistently expressed in uterine carcinosarcomas
    Joseph, N. E.
    Stricker, T. P.
    Montag, A. G.
    LABORATORY INVESTIGATION, 2008, 88 : 208A - 208A
  • [8] Dual Targeting Enhancer of Zeste Homolog 2 and Histone Deacetylases in Human Uterine Sarcoma Cells
    Omran, Mervat Mostafa
    Vafaei, Somayeh
    Al-Hendy, Ayman
    Yang, Qiwei
    REPRODUCTIVE SCIENCES, 2023, 30 : 225A - 226A
  • [9] Meta-analysis of Genetic polymorphism of Enhancer of Zeste Homolog2 gene in cancer susceptibility
    Gautam, Nisha
    Kaur, Mandeep
    Kashyap, Surender
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1079 - 1092
  • [10] Uterine Epithelial Development and Enhancer of Zeste Homolog 2 It Is Important for More than Just Cancer
    Wang, Xiyin
    Hawkins, Shannon M.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (06): : 1176 - 1177